LAB SYSTEMSINDEX

Map the system. Preserve the evidence. Test the handoff.

Lab automation · Sample-custody analysis

A Biosero workcell schedule cannot prove sample custody

Biosero presents Green Button Go for scheduling, orchestrating, and integrating laboratory instruments, devices, robotics, and workcells. An automation schedule can coordinate execution, but sample custody still requires persistent material identity, location, container, handoff, condition, action, result, exception, and accountable review.

Editorial figure by Lab Systems Index. Source context: Biosero official product record.

Keep material identity outside the scheduler's assumptions

Biosero's official product record supports a specific operating role: Green Button Go schedules and coordinates automated laboratory equipment and workflows. The scheduler can know that a planned job requires a plate at a location and can direct devices through a sequence. Custody requires more. The laboratory must establish that the physical plate, tube, vial, rack, aliquot, or other material is the intended object and that its identity persisted through every transfer and transformation.

The record should link study, experiment, protocol, batch or run, sample and parent sample, container, barcode or other identifier, position, quantity or volume, concentration where relevant, storage condition, expiration or stability context, preparation state, and current location. It should show which system owns each identifier and how mismatches are resolved. A worklist row, device position, or schedule token should not silently become authoritative material identity.

Record each handoff as an executed event

Automation can move material across storage, transport, liquid handling, incubation, detection, imaging, and other devices. Buyers should ask what evidence exists at every handoff: source and destination, expected and observed identifiers, device, method or command, timestamp, operator or service identity, quantity change, environmental condition, acknowledgement, and result. The distinction between requested, accepted, started, completed, and verified events should survive retries and asynchronous integrations.

Test transfers that do not complete cleanly. A gripper can fail, a plate can be absent or misoriented, a barcode can be unreadable, a well can contain insufficient volume, a device can finish after a timeout, a message can be duplicated, or an operator can intervene. The custody chain should show the last known state, uncertainty, physical check, quarantine or disposition, corrective action, and restart basis rather than allowing the scheduler to advance because a nominal step timed out or returned a generic success.

Separate orchestration logs from scientific and regulated records

A device command log, automation history, LIMS record, ELN entry, instrument raw data, method, result, audit trail, and quality decision can describe different aspects of the same run. The architecture should define which record is authoritative for material identity, method version, instrument state, raw data, derived result, review, release, and retention. Links and reconciliation are safer than declaring that one platform replaces every adjacent system.

Change control should cover workflow definitions, device drivers, mappings, APIs, schedules, resource rules, user roles, and recovery procedures. Validation or assurance should be based on intended use and process risk, with representative challenges for identity, sequencing, concurrency, failure recovery, data integrity, and human intervention. Vendor positioning does not establish that a reader's configured workcell is suitable for a regulated purpose.

Prove custody through an exception-rich run

A serious evaluation should include a normal run plus a duplicate identifier, missing plate, wrong location, partial transfer, failed device, late response, manual move, aborted run, resumed run, rerun, depleted sample, and material placed in quarantine. Ask the team to reconstruct where every affected item was at each point and which evidence supports the final state. Measure unresolved identities, manual reconciliations, duplicate or missing events, exception aging, and time to restore a trustworthy chain.

The registered Biosero record establishes provider positioning for laboratory automation orchestration; it does not establish a reader's sample identity, custody completeness, device performance, scientific validity, data integrity, safety, validation status, or regulatory suitability. Laboratory, automation, scientific, quality, data, IT, safety, and records owners should test the actual workcell and integrations. Scheduling is valuable when it coordinates work without being mistaken for the full evidence of what happened to the material.

Enterprise buyer test

Translate this change into the exact population, record type, workflow stage, decision owner, effective date, and evidence that could be affected. Ask current or prospective providers to demonstrate the named workflow with representative data and an exception—not a polished feature tour. Record what official documentation establishes, what a provider states, what the team observes, and what remains unresolved.

A defensible review also identifies the dependency outside the product. Authority interpretation, policy configuration, data quality, integrations, human judgment, approval rights, release governance, training, and retained evidence may remain customer or service responsibilities. The evaluation should preserve those boundaries instead of treating a technology claim as the complete operating model.

What we will watch next

Lab Systems Index will watch the named source and affected market records for later evidence that changes status, scope, availability, implementation timing, workflow consequence, or the limits of the initial report. A later announcement does not silently overwrite this dated account; the change ledger preserves the sequence.

Primary source: Biosero official product record · Official provider product record.

Evidence boundary: Independent analysis of Biosero's official product record, reviewed August 15, 2026. Provider-documented capabilities were not independently tested. This article is not laboratory, scientific, quality, safety, validation, regulatory, data-integrity, or implementation advice and does not establish sample identity, custody completeness, device performance, method execution, result validity, or regulated suitability.

Editorial record: Published August 15, 2026; updated August 15, 2026. Corrections policy.

Related organizations

Explore all